Tildacerfont-d8 is a deuterium-labeled derivative of Tildacerfont, a potent and orally bioavailable antagonist of the corticotropin-releasing factor type 1 (CRF1) receptor. It effectively lowers levels of adrenocorticotropic hormone (ACTH) and adrenal androgens, demonstrating a favorable safety profile. Tildacerfont-d8 is valuable for research into congenital adrenal hyperplasia and related hormonal regulation studies, facilitating the investigation of CRF1 receptor dynamics.
Tildacerfont-d8 is a deuterium-labeled derivative of Tildacerfont, a potent and orally bioavailable antagonist of the corticotropin-releasing factor type 1 (CRF1) receptor. It effectively lowers levels of adrenocorticotropic hormone (ACTH) and adrenal androgens, demonstrating a favorable safety profile. Tildacerfont-d8 is valuable for research into congenital adrenal hyperplasia and related hormonal regulation studies, facilitating the investigation of CRF1 receptor dynamics.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: